Healthy Skepticism Library
Items where at least one author is a Healthy Skepticism member
HSL1419
Jureidini J.
Does the International Consensus Statement on ADHD leave room for healthy scepticism?
Eur Child Adolesc Psychiatry 2002 Oct;11:(5):240
HSL1892
Molloy W, Strang D, Guyatt G, Lexchin J, Bedard M, Dubois S, Russo R.
Assessing the quality of drug detailing.
J Clin Epidemiol 2002 Aug;55:(8):825-32
HSL17906
Moynihan R
Celebrity selling
BMJ 2002 Jun 1;324:(7349):1342
http://www.bmj.com/cgi/content/citation/324/7349/1342?HITS=10&hits=10&stored;_search=&author1=Moynihan%2C%2BR&maxtoshow;=&FIRSTINDEX=0&resourcetype=1,2,3,4,10&searchid=1023661467365_9984&RESULTFORMAT;=
HSL5849
Toop L, Richards D.
DTCA in New Zealand: the challenge of finding an acceptable balance
Br J Gen Pract. 2002 Apr 1;52:(477):341
HSL5592
Shann F.
Research in developing countries.
N Engl J Med 2002 Feb 21;346:(8):627-8
HSL27
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002;324:278-279
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278
HSL2148
WHO Department of Essential Drugs & Medicines Policy
Drug Promotion Database
: WHO Department of Essential Drugs & Medicines Policy 2002
http://www.drugpromo.info/
HSL13290
Lexchin J, Mintzes B.
Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No
Journal of Public Policy and Marketing 2002;21:(2):194-201
http://www.marketingpower.com/content18627.php
HSL5593
Shann F.
Uses of error: the wrong research costs lives.
Lancet 2001 May 26;357:(9269):1691
http://linkinghub.elsevier.com/retrieve/pii/S0140673600048790
HSL34
Vlassov V, Mansfield P, Lexchin J, Vlassova A.
Do drug advertisements in Russian medical journals provide essential information for safe prescribing?
West J Med 2001;174:391-394
HSL2156
Jureidini J, Mansfield P.
Does drug promotion adversely influence doctors’ abilities to make the best decisions for patients?
Australasian Psychiatry 2001;9:95-99
http://www.blackwell-synergy.com/doi/full/10.1046/j.1440-1665.2001.00313.x?prevSearch=allfield%3A%28Jureidini+J+and+Mansfield+P%29
HSL6960
Gifts: a transcript of a television report
MaLAM International News 2000 Sep-Oct;18:(9-10):1-4
HSL856
Irwig LM, Loy CT, Chapman S, Glasziou PP, Mansfield PR, Salkeld GP, Walton MM.
!nform test kits distributed with the MJA.
Med J Aust 2000 May 15;172:(10):518-9
HSL2242
Roughead L, Semple S, Vitry A.
The Value of Pharmacist Professional Services in the Community: A systematic review of the literature 1990-2002
2000
HSL1032
Lexchin J.
Don't bite the hand that feeds you.
West J Med 1999 Oct;171:(4):238-9
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=10578675
HSL6891
Memoirs of methods used to sell drugs
MaLAM International News 1999 Mar-Apr;17:(3-4):1-6
HSL6888
Advertising of antibacterials
Health Skepticism 1999 Feb;2:(2):1-5
HSL6886
Advertising of CCBs for hypertension
Health Skepticism 1999 Jan;2:(1):3-4
HSL394
Lexchin J.
Drug not considered a first-line agent.
Can Fam Physician 1998 Nov;44:2376
HSL6832
ACE inhibitors
Health Skepticism 1998 Nov;1:(1):3-4
HSL396
Lexchin J.
Intellectual property rights and drug prices.
Lancet 1998 Aug 15;352:(9127):582
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-4FWV34C-NC&_coverDate=08%2F15%2F1998&_alid=305534210&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=85140d6e65b19947f465cc4160cdcac0
HSL393
Lexchin J.
Residents and pharmaceutical representatives.
Can Fam Physician 1998 Jul;44:1448:
HSL6816
MaLAM letter follow up—MaLAM apologises but we remain concerned about thepromotion of Atarax
MaLAM International News 1998 Jul-Aug;16:(7-8):1-5
HSL395
Lexchin J.
Improving the appropriateness of physician prescribing.
Int J Health Serv 1998;28:(2):253-67
HSL1550
Mansfield PR.
MaLAM, a medical lobby for appropriate marketing of pharmaceuticals.
Med J Aust 1997 Dec 1-15;167:(11-12):590-2
http://www.mja.com.au/public/issues/xmas/mansfield/mansfield.html
HSL6776
Mansfield P, Vitry A.
Re: the promotion of prescription products in Australia
1997 Dec;
HSL418
Vitry A, Mansfield P.
Drug advertisements in medical journals.
Lancet 1997 Nov 15;350:(9089):1477-8
http://www.thelancet.com/search/results?search_searchuri=%2Fsearch%2Fadvanced&search_resulturi=%2Fsearch%2Fresults&search_preview=no&search_reqfirst=1&search_reqcount=20&search_submode=advanced&update_search=no&search_mode=platform&search_cluster=phoenix&search_text1=Vitry+A&search_within1=au&search_operator1=and&search_text2=Mansfield+P&search_within2=au&search_operator2=and&search_text3=advertisements&search_within3=ti&restrictterm_lancet=lancet&restrictname_lancet=lancet&restricttype_lancet=journal&restrictdesc_lancet=The+Lancet&restrictname_laneur=laneur&restricttype_laneur=journal&restrictdesc_laneur=The+Lancet+Neurology&restrictname_laninf=laninf&restricttype_laninf=journal&restrictdesc_laninf=The+Lancet+Infectious+Diseases&restrictname_lanonc=lanonc&restricttype_lanonc=journal&restrictdesc_lanonc=The+Lancet+Oncology&search_dateradio=combo&search_datecombo=0%3AALL&search_monthstartcombo=1&search_yearstart=1996&search_monthendcombo=1&search_yearend=2005&search_wordsexactly=yes&search_sort=relevance&Submit=Search
HSL545
Lexchin J.
Code of marketing practices.Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada
Can Fam Physician. 1997 11 01;43:
HSL1894
Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May;43:941-5
HSL392
Lexchin J.
[Pharmaceutic regulation and inadequate drug prescription in Canada: the case of psychotropic drugs in the 1960s and early 1970s]
Sante Ment Que. 1997 Spring;22:(1):283-300
HSL547
Lexchin J.
Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
CMAJ 1997 Feb 1;156:(3):351-6
http://www.cmaj.ca/cgi/reprint/156/3/351
HSL520
Shear NH, Black F, Lexchin J.
Physician-detailer interaction—II.
Can J Clin Pharmacol 1997;4:(1):10
HSL538
Mansfield P, Lexchin J.
MaLAM: networking for scientific integrity in drug promotion.
Essential Drugs Monitor 1997(24):5
http://healthyskepticism.org/library/EDM/24/Page5.pdf
HSL539
Mansfield P.
Can health professionals lobby drug companies to upgrade from misleading promotion to reliable service?
Australian Prescriber 1997;20:(Supp 1):150
HSL546
Lexchin J.
Recent progress in drug advertising
Can Fam Physician 1997;43:1041-1042
HSL585
Vitry A, Mansfield P.
Promotion of Coversyl by Servier.
Lancet 1996 May 18;347:(9012):1411
HSL639
Anderson GM, Lexchin J.
Strategies for improving prescribing practice.
CMAJ 1996 Apr 1;154:(7):1013-7
http://www.cma.ca/cmaj/vol-154/1013e.htm
HSL586
Vitry A.
Pharmaceutical promotion: drug advertising affects your prescribing
Australian Prescriber 1996;19:103
HSL594
Shear NH, Black F, Lexchin J.
Examining the physician-detailer interaction
Can J Clin Pharmacol 1996;3:(4):175-179
HSL609
Lexchin J.
Direct to consumer advertising of prescription drugs: the next steps
Can J Clin Pharmacol 1996;3:(2):65
HSL364
Lexchin J.
Deception by design: Pharmaceutical promotion in the Third World
Penang: Consumers International 1995
HSL667
Lexchin J.
Is there a bias in industry supported clinical research
Can J Clin Pharmacol 1995;2:15-18
HSL6149
Lexchin J.
Agents against pediatric diarrhea. Assessing the information companies supply to Canadian physicians
Can Fam Physician. 1994 Dec 01;40:2082-7
HSL6155
Mansfield PR.
MaLAM: encouraging trustworthy drug promotion
Essential Drugs Monitor 1994;(17):6
HSL2157
Lexchin J.
Interactions between physicians and the pharmaceutical industry: what does the literature say?
CMAJ 1993 Nov 15;149:(10):1401-7
http://www.cmaj.ca/cgi/content/abstract/149/10/1401?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Lexchin+J&andorexactfulltext=and&searchid=1124491359271_2918&stored_search=&FIRSTINDEX=0&sortspec=relevance&resourcetype=1&journalcode=cmaj
HSL5164
Lexchin J.
Physicians and drug companies interact.
Can Fam Physician 1993 Sep 01;39:1881-2
HSL4641
Re: the promotion of aspirin
1992 Nov 1;
HSL3984
Wade VA, Mansfield PR, McDonald PJ.
Drug companies' evidence to justify advertising.
Lancet 1989 Nov 25;2:(8674):1261-3
HSL857
Mansfield PR.
Drug advertising.
Lancet 1989 May 20;1:(8647):1137-8
HSL2055
Mansfield PR.
Drug Advertising
Med J Aust 1987 Jun 15;146:(12):660-661
HSL861
Mansfield P.
Phenylbutazone.
Med J Aust 1986 Jan 6;144:(1):55
HSL862
Mansfield P.
Phenylbutazone.
Med J Aust 1985 Sep 2;143:(5):219-20
HSL8523
Jureidini JN, Mansfield PR.
The scope of the problem of the relationship between drug companies and doctors
Maitra B, Timimi S. Critical Voices in Child and Adolescent Mental Health London: Free Association Books 2006
http://www.fabooks.com/book.php?id=434
